Table 3.
Ceftazidime | Levofloxacin | Minocycline | TIM | SXT | Ciprofloxacina | Moxifloxacina | Tigecyclinea | |
---|---|---|---|---|---|---|---|---|
Initial Isolates (N=71) | 30 (42.3) | 59 (83.1) | 71 (100) | 48 (67.6) | 70 (98.6) | 10 (28.2) | 69 (97.2) | 62 (87.3) |
Serial Isolates (N=26) | 1 (3.8) | 8 (30.8) | 26 (100) | 8 (30.8) | 21 (80.8) | 2 (7.7) | 23 (88.5) | 6 (23.1) |
SXT – trimethoprim-sulfamethoxazole; TIM – ticarcillin-clavulanic acid
Susceptibility defined for ciprofloxacin, moxifloxacin, and tigecycline by MIC ≤ 2 μg/ml, ≤ 4 μg/ml, and ≤ 2 μg/ml respectively based on values used in published literature